Norges Bank Magenta Therapeutics, Inc. Transaction History

Norges Bank

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 08, 2019	SELL	$5.57 - $11.65 $39,875 - $83,402	-7,159 Closed	0 $0
Q3 2018 Nov 12, 2019	BUY	$11.32 - $15.7 $81,039 - $112,396	7,159 New	7,159 $86,000
Q3 2018 Nov 09, 2018	SELL	$11.32 - $15.7 $849,000 - $1.18 Million	-75,000 Closed	0 $0
Q2 2018 Aug 12, 2019	BUY	$13.5 - $14.52 $1.01 Million - $1.09 Million	75,000 New	75,000 $1.01 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.